The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 04, 2022
Filed:
Mar. 03, 2016
Applicant:
Wilfred Jefferies, Surrey, CA;
Inventors:
Wilfred Jefferies, Surrey, CA;
Iryna Yuriyivna Saranchova, Surrey, CA;
Assignee:
CAVA HEALTHCARE INC., Surrey, CA;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/20 (2006.01); A61K 35/17 (2015.01); C12N 5/078 (2010.01); C12N 5/0783 (2010.01); G01N 33/574 (2006.01); C07K 14/54 (2006.01); C07K 14/47 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01); C12Q 1/6886 (2018.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 38/20 (2013.01); A61K 35/17 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); C07K 14/4718 (2013.01); C07K 14/54 (2013.01); C12N 5/0636 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57407 (2013.01); G01N 33/57423 (2013.01); G01N 33/57434 (2013.01); G01N 33/57438 (2013.01); G01N 33/57488 (2013.01); A61K 2039/5158 (2013.01); C12N 2501/2333 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/54 (2013.01); G01N 2800/52 (2013.01);
Abstract
The present invention provides methods of modulating of cancer immunity using type 2 innate lymphoid cells (IL-C2s), interleukin 33 (IL-33), IFI44 or combination thereof. Also provided are methods of preventing tumor metastasis and/or cancer progression by treatment with therapies comprising type 2 innate lymphoid cells (ILC2s), interleukin 33 (IL-33), IFI44 or combination thereof. Also provided are diagnostic methods for assessing cancer prognosis.